Wealth Enhancement Advisory Services, LLC Recursion Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,910 shares of RXRX stock, worth $57,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,910
Previous 24,230
54.97%
Holding current value
$57,604
Previous $128,000
57.03%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
363Shares Held
285MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$184 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$170 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$129 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$91.4 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$77.4 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $953M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...